The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2020 | The importance of molecular testing
Sanjay Popat, BSc, MBBS, FRCP, PhD, The Royal Marsden NHS Foundation Trust, London, UK, discusses the importance of molecular testing and using these findings to achieve the best possible treatment outcomes. Prof. Popat highlights the formation of the Genomic Laboratory Hubs (GLHs) in England, which will help to coordinate the national approach to providing molecular diagnostic tests to patients. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.
